Lixte Biotechnology Holdings, Inc. (LIXT)

CIK 1335105 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lixte Biotechnology Holdings, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 202610-Q0001493152-26-038001
Jul 31, 2026SCHEDULE 13G0002100119-26-001514
Jul 31, 20268-K0001493152-26-035561
Jul 27, 2026DEF 14A0001493152-26-034713
Jul 17, 2026PRE 14A0001493152-26-033809
Jul 10, 20268-K0001493152-26-032802
Jul 2, 202640001493152-26-031896
Jul 2, 202640001493152-26-031890
Jul 2, 202630001493152-26-031723
Jul 2, 202640001493152-26-031893
Jul 2, 202640001493152-26-031882
Jul 2, 202640001493152-26-031885
Jul 2, 202640001493152-26-031888
Jul 2, 20268-K0001493152-26-031870
Jun 18, 20268-K0001493152-26-029308
Jun 16, 20268-K0001493152-26-028878
Jun 9, 2026SCHEDULE 13G0001213900-26-066986
Jun 4, 2026424B50001493152-26-027286
Jun 4, 20268-K0001493152-26-027307
Jun 1, 202630001493152-26-026607
Jun 1, 20268-K0001493152-26-026544
Jun 1, 202640001493152-26-026608
May 14, 202610-Q0001493152-26-023150
Apr 17, 20268-K0001493152-26-017833
Apr 17, 202640001493152-26-017854